Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1975;46:385-388
© 1975 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BELIZAN, J. M.
Right arrow Articles by CALDEYRO-BARCIA, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BELIZAN, J. M.
Right arrow Articles by CALDEYRO-BARCIA, R.

Effects of Orciprenaline on Uterine Contractility and Maternal Heart Rate

A Quantitative Study

JOSE M. BELIZAN, MD, ANGEL G. DIAZ, MD, CARLOS ABUSLEME, MD, JUAN J. POSEIRO, MD and ROBERTO CALDEYRO-BARCIA, MD

From the Latin American Center of Perinatology and Human Development (PAHO/WHO). Montevideo. Uruguay.

Amniutic pressure and maternal heart rate were recorded continuously and simultaneously in 15 women in labor or prelabor. Orciprenaline (Alupent) was administered through an intravenous infusion pump at the rate of 10 and 20 µg/min. Uterine contractility and maternal and fetal heart rate were measured before its onset and during the infusion. The development and stabilization of the effects were studied. Continuous intravenous infusions of orciprenaline at rates of 10 and 20 µg/min are recommended. They proved to be very useful in obtaining uterine inhibition with a minimum of undesirable side effects.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 by the American College of Obstetricians and Gynecologists.